Anne Scheiber
1893-1995 · One apartment, one salary, fifty-one years.
Buy, and never sell
~17% a year○
1944-1995 · about $5,000 to about $22m
Overview
She retired from the Internal Revenue Service in 1944, aged fifty-one, on a small pension and about five thousand dollars in savings, having been passed over for promotion for twenty-three years despite auditing returns better than the men who were promoted. She invested that money alone, from a rent-controlled apartment on the Upper West Side, and never sold anything. When she died in 1995 at a hundred and one, it was about twenty-two million dollars. She left all of it to Yeshiva University, to fund scholarships for women.
The open question
She is the only person in this library whose record an ordinary person could have repeated. No fund, no leverage, no clients, no access, no fees. Which sets the open question sharply: what actually did the work here — the selection, or fifty-one years and every dividend reinvested?
Background
Born in 1893 to a poor Jewish immigrant family in New York, the third of nine children. Her father died young; she went to work at fifteen as a bookkeeper and put herself through law school at night. She joined the IRS as an auditor and spent twenty-three years examining other people's tax returns — she never rose beyond the grade she entered at, and told people plainly that she believed it was because she was a woman and Jewish.
She retired in 1944 on a pension of a few thousand dollars a year, and she was not wrong about the promotions: her assessments were used, and the men who signed them advanced.
Style, and how it evolved
She had already seen which businesses actually made money. Two decades of auditing returns is an unusual training: not a theory about franchises, but a filing cabinet of evidence about which ones threw off cash reliably, year after year, in good conditions and bad.
Brand-name consumer and pharmaceutical franchises. Coca-Cola, PepsiCo, Bristol-Myers, Schering-Plough, and a long tail of similar names. Businesses she could understand, whose products people bought regardless.
Every dividend reinvested, and almost nothing ever sold. This is where the money came from, and it is the least interesting sentence to read and the hardest thing to do.
She read the reports and went to the meetings, for decades, as a private shareholder with no professional standing whatever.
There is no evolution to describe. She did the same thing for fifty-one years, through 1962, 1973-74, 1987 and 1990, and the absence of change is the entire method.
Performance
paid offa decisiona losswalked awaythe lifeshaded columns are the crashes — hover any mark
About $5,000 in 1944 to about $22m in 1995 — roughly 17-18% a year compounded across fifty-one years, if the starting figure is right. ○ The end figure is solid: it comes from a documented bequest. The starting figure comes from press accounts after her death and has never been rigorously established, and small changes to it move the implied rate a great deal.
| Year | ||
|---|---|---|
| 1908 | Leaves school at fifteen to work as a bookkeeper | ○ |
| 1920s-44 | Twenty-three years auditing at the IRS, never promoted | ✓ |
| 1944 | Retires at 51 with a small pension and about $5,000 | ○ |
| 1944-95 | Buys consumer and pharmaceutical franchises; reinvests everything | ✓ |
| 1995 | Dies at 101; leaves about $22m to Yeshiva University | ✓ |
✓ documented · ○ from press accounts rather than records
Case studies
The training nobody would have designed. Auditing tax returns is not analysis, and it gave her something analysis often does not: two decades of direct evidence about which businesses reliably produced cash and which only appeared to. The mechanism: she was selecting on realised economics rather than on narrative, and she had seen the numbers before they were dressed for publication. ✓
Fifty-one years of not selling. She held through the 1962 break, the 1973-74 collapse, Black Monday, and a series of bear markets in the pharmaceutical names she owned most of. No trimming, no rebalancing, no reaction. The mechanism: the return is arithmetic — reinvested dividends on a growing earnings base for half a century — and the only requirement is that nothing interrupts it. Almost everything an investor does is an interruption. ✓
The bequest. She left the entire estate to fund scholarships for women, having told her lawyer she did not want other women to meet what she had met. She had no relationship with the university and it had no idea she existed. ✓
The other side of the record
A record this good is where scepticism is most worth spending, so:
It is a single observation, and the most over-told parable in retail investing. One person, one lifetime, no control group. There is no way to separate her selection from the extraordinary run those particular consumer and pharmaceutical franchises had over exactly that half-century.
The starting number is not documented. Every calculation of her compound rate rests on a $5,000 figure that appears in press coverage after her death. If it was larger — and a career civil servant with a pension may well have had more — the implied skill falls sharply.
Longevity is doing an enormous amount of the work. Fifty-one years is the variable almost nobody has. The same rate over thirty years produces about a tenth as much money, and the parable rarely mentions that she was investing until she was a hundred and one.
Her life was not the recommendation the story implies. She lived alone, in one rent-controlled room, spending almost nothing, largely without company. Presenting that as a lifestyle lesson rather than as the cost of the outcome is dishonest about what was actually required.
And survivorship is total. Nobody wrote about the people who did the same thing with the wrong six companies.
Key lessons
- Compounding needs an uninterrupted run more than it needs a good rate. The rate here was good; the fifty-one years were decisive.
- Reinvested dividends are most of the arithmetic, and they only work if you never spend or interrupt them.
- Evidence about realised economics beats a story about future ones. She had seen the returns before they were narrated.
- Almost everything an investor does is an interruption — a trim, a rotation, a reaction to news.
- Access was never the requirement. Nothing she did was unavailable to any person with a small salary, a library card and patience, which is why this page is here.
Reading and links
- Yeshiva University's account of the 1995 bequest — the primary documented source, and the only figure in her story that is solid.
- Contemporary press coverage from 1995-96 — where the $5,000 figure and most of the biographical detail originate. Read as journalism rather than record.
- The Millionaire Next Door — Stanley and Danko, 1996. Not about her, and the best available context for how ordinary the mechanism is.
Marked ✓ where documented and ○ where it comes from press accounts rather than records. This is a profile of an investor, not a view on any security.
Primary sources
Go to the thing itself. These are the subject’s own publications or an institution’s own site. No bookseller links, and no referral arrangements — a reading list that earns per click is not a reading list.
- Yeshiva UniversityThe scholarships her estate funds are the only rigorously documented figure in her story.
Profiles of investors, not views on any security, and not personal advice. Figures are marked ✓ where they are documented and ○ where they rest on secondary or private accounts — investing biography is heavily mythologised and the well-known numbers drift with each retelling. Capital is at risk.
Corrections and right of reply. Where a criticism is made of a named person it is stated as a specific measure over a stated period, attributed to its source, and separated from opinion. Assessments are opinion, honestly held, on facts believed accurate at the date shown. If anyone profiled here — or anyone acting for them — believes a fact is wrong, it will be corrected promptly and visibly, and a reply will be published alongside it on request.